info@synchemia.com | sales@synchemia.com 
9766925136 
N-Di Nitroso Clonidine
Specifications
Product name
N-Di Nitroso Clonidine
SRC CAT No
SRC-N014324
CAS No
148950-50-9
Mol.F.
C9H7Cl2N5O2
Mol.Wt.
288.1g/mol
Related CAS No.
NA
Inv Status
UNDER SYNTHESIS
Chemical Structure
Product Overview
Description
Chemical Name
N-(2,6-Dichlorophenyl)-1,3-dinitrosoimidazolidin-2-imine
HSN Code
38229010
Synonym
N.A
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Clonidine is a medication that treats high blood pressure. It relaxes your blood vessels. This decreases blood pressure and the amount of work your heart has to do.DI-Nitroso-Clonidine is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
DI-Nitroso-Clonidine CAS NO: 148950-50-9 chemically represented as N-(2,6-Dichlorophenyl)-1,3-dinitrosoimidazolidin-2-imine.Synchemia is the leading manufacturing and exporter of DI-Nitroso-Clonidine .We supply DI-Nitroso-Clonidine with detailed characterization data compliance with regulatory guidelines.
Related Products
N-Nitroso Metoprolol Dimer Impurity 1
| CAT No | SRC-N0143108 |
| CAS No | NA |
| Mol.F. | C12H27N3O4 |
| Mol.Wt. | 277.37 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Mebeverine EP Impurity B
| CAT No | SRC-N0143109 |
| CAS No | NA |
| Mol.F. | C12H18N2O2 |
| Mol.Wt. | 222.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Metformin EP Impurity B
| CAT No | SRC-N0143110 |
| CAS No | NA |
| Mol.F. | C4H7N9O |
| Mol.Wt. | 197.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Metformin EP Impurity E
| CAT No | SRC-N0143111 |
| CAS No | NA |
| Mol.F. | C3H8N6O |
| Mol.Wt. | 144.14 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Metformin Impurity 3
| CAT No | SRC-N0143112 |
| CAS No | NA |
| Mol.F. | C2H5N5O3 |
| Mol.Wt. | 147.09 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Metformin Impurity 4
| CAT No | SRC-N0143113 |
| CAS No | NA |
| Mol.F. | C4H8N6O |
| Mol.Wt. | 154.13 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N2,N4-Dinitroso Moxifloxacin Impurity
| CAT No | SRC-N0143114 |
| CAS No | NA |
| Mol.F. | C7H12N4O2 |
| Mol.Wt. | 184.2 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Moxifloxacin EP Impurity E
| CAT No | SRC-N0143115 |
| CAS No | NA |
| Mol.F. | C20H21FN4O5 |
| Mol.Wt. | 416.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Moxifloxacin EP Impurity H
| CAT No | SRC-N0143116 |
| CAS No | NA |
| Mol.F. | C22H25FN4O5 |
| Mol.Wt. | 444.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Nintedanib Acetyl Impurity
| CAT No | SRC-N0143117 |
| CAS No | NA |
| Mol.F. | C26H22N4O5 |
| Mol.Wt. | 470.49 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Nintedanib Acid
| CAT No | SRC-N0143118 |
| CAS No | NA |
| Mol.F. | C30H30N6O5 |
| Mol.Wt. | 554.61 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Nicotine EP Impurity G
| CAT No | SRC-N0143119 |
| CAS No | NA |
| Mol.F. | C10H13N3O |
| Mol.Wt. | 191.23 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Cabozantinib
| CAT No | SRC-N0143120 |
| CAS No | NA |
| Mol.F. | C28H23FN4O6 |
| Mol.Wt. | 530.5 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Cabozantinib Nitroso Impurity 3
| CAT No | SRC-N0143121 |
| CAS No | NA |
| Mol.F. | C15H16N2O7 |
| Mol.Wt. | 336.3 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
Cabozantinib Nitroso Impurity 4
| CAT No | SRC-N0143122 |
| CAS No | NA |
| Mol.F. | C23H18FN3O4 |
| Mol.Wt. | 419.4 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
N-Nitroso Cabozantinib Carboxylic Acid
| CAT No | SRC-N0143123 |
| CAS No | NA |
| Mol.F. | C22H19N3O7 |
| Mol.Wt. | 437.41 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
